化学混合物的生物活性分析,用于危险性特征
Xiaojing Li1, Jiarui Zhou1, Yaohui Bai2
1Centre for Environmental Research and Justice (CERJ), School of Biosciences, The University of Birmingham, Birmingham B15 2TT, U.K.
Environmental science & technology
|December 20, 2024
概括
评估水中的化学混合物是一项挑战. 这项研究使用达芬尼亚基因表达来分析环境混合物毒性,确定80个代谢途径并揭示潜在的危害.
科学领域:
- 环境毒理学环境毒理学
- 生态毒理学 生态毒理学
- 生物分子反应概况分析
背景情况:
- 化学毒性评估传统上侧重于单一物质,忽视了现实世界的环境混合物.
- 复杂化学混合物在水生生态系统中的毒性在很大程度上是未知的,这阻碍了有效的监管.
- 了解混合物毒性对于保护人类健康和环境至关重要.
研究的目的:
- 应用使用大夫尼大的生物活性分析,以评估环境水中的真实化学混合物的生物分子影响.
- 为了将水样中的已识别的化学成分与大夫尼亚的特定基因表达模式相关联.
- 确定受环境化学混合物影响的代谢途径,并发现潜在的新型危险.
主要方法:
- 暴露大夫尼亚大30环境水样查河.
- 测量暴露达芬尼亚的基因表达响应概况.
- 多块相关性分析,将化学成分与观察到的基因表达模式联系起来.
主要成果:
- 通过化学混合物激活的80种代谢途径的识别,包括无机离子,重金属,PAH,工业化学品,生物杀虫剂,农药和药品.
- 在特定的化学混合物和大夫尼亚的基因表达特征之间建立了相关性.
- 发现已知的生物活性特征和与潜在危害相关的新途径.
结论:
- 在达芬尼亚的基因表达监测提供了一种可行的方法,以减少现实世界混合物毒性评估的复杂性.
- 这种数据驱动的方法描述了复杂混合物中定义的化学成分的生物分子效应.
- 该研究强调了使用哨兵物种来了解环境化学混合物影响的潜力.
更多相关视频
09:04Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
Published on: April 18, 2019
12.4K
09:38Single-throughput Complementary High-resolution Analytical Techniques for Characterizing Complex Natural Organic Matter Mixtures
Published on: January 7, 2019
8.5K
相关概念视频
Types of Toxins
1.6K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.6K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Structure-Activity Relationships and Drug Design
510
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
510
